Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
| Image |  |
|---|---|
| Description | scientific article published on 13 July 2015 |
| Author/s | |
| Publication date | July 13, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |